KBC Group’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

KBC Group’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-130,800	Closed	-$13.4M	–	1497
2014 Q4	$13.4M	Buy	130,800 +107,190	+454%	+$10.3M	0.16%	145
2014 Q3	$2.04M	Sell	23,610 -39,697	-63%	-$3.52M	0.07%	341
2014 Q2	$5.71M	Buy	63,307 +1,493	+2%	+$112K	0.07%	356
2014 Q1	$4.55M	Sell	61,814 -98,730	-61%	-$6.89M	0.07%	315
2013 Q4	$10.9M	Sell	160,544 -14,131	-8%	-$919K	0.17%	160
2013 Q3	$10.6M	Sell	174,675 -18,065	-9%	-$1.1M	0.17%	161
2013 Q2	$9.77M	Buy	+192,740	New	+$11.1M	0.18%	133

KBC Group's COV Position: Q1 2015 in Review

KBC Group sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 130,800 shares — an estimated $13.4M sold.

KBC Group first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $13.4M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

KBC Group reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
KBC Group sold 130,800 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $13.4M.
KBC Group first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
KBC Group's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $13.4M in Q4 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on KBC Group's 13F filing for Q1 2015, filed 30 Apr 2015.